12-105366661-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145199.2(C12orf75):āc.152A>Gā(p.Asn51Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000505 in 1,545,028 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001145199.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C12orf75 | NM_001145199.2 | c.152A>G | p.Asn51Ser | missense_variant | 4/6 | ENST00000443585.6 | NP_001138671.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C12orf75 | ENST00000443585.6 | c.152A>G | p.Asn51Ser | missense_variant | 4/6 | 2 | NM_001145199.2 | ENSP00000448536 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000325 AC: 5AN: 153702Hom.: 0 AF XY: 0.0000368 AC XY: 3AN XY: 81570
GnomAD4 exome AF: 0.0000452 AC: 63AN: 1392682Hom.: 0 Cov.: 26 AF XY: 0.0000538 AC XY: 37AN XY: 687422
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152346Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74498
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.152A>G (p.N51S) alteration is located in exon 4 (coding exon 4) of the C12orf75 gene. This alteration results from a A to G substitution at nucleotide position 152, causing the asparagine (N) at amino acid position 51 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at